BioCentury
ARTICLE | Clinical News

Vanoxerine: Phase III started

September 21, 2015 7:00 AM UTC

Laguna began the double-blind, placebo-controlled, international Phase III RESTORE SR trial to evaluate a single dose of 400 mg oral vanoxerine in about 600 patients. ...